# CEVIMELINE HYDROCHLORIDE
> **ANDA218290** · Abbreviated New Drug Application (Generic) · Sponsor: BIONPHARMA · Approved 2023-11-08
## Drug
- **FDA Application Number:** ANDA218290
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CEVIMELINE HYDROCHLORIDE
- **Generic name:** CEVIMELINE HYDROCHLORIDE
- **Active ingredients:** CEVIMELINE HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BIONPHARMA
- **Manufacturer:** Bionpharma Inc
- **First approval:** 2023-11-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218290)
---
*AI Analytics · CC0 1.0*